{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:32:39Z","timestamp":1794522759265,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11427-023-2662-y","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:37:49Z","timestamp":1752208669000},"page":"2950-2964","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["SUMO-activating enzyme subunit 1 (SAE1) promotes non-small cell lung cancer metastasis by promoting the epithelial-mesenchymal transition through the SUMOylation of N-cadherin"],"prefix":"10.1007","volume":"68","author":[{"given":"Yaru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantao","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"2662_CR1","first-page":"330","volume":"2","author":"S Amente","year":"2012","unstructured":"Amente, S., Lavadera, M.L., Palo, G.D., and Majello, B. (2012). SUMO-activating SAE1 transcription is positively regulated by Myc. Am J Cancer Res 2, 330\u2013334.","journal-title":"Am J Cancer Res"},{"key":"2662_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO;2-7","volume":"190","author":"I Buschmann","year":"2000","unstructured":"Buschmann, I., and Schaper, W. (2000). The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 190, 338\u2013342.","journal-title":"J Pathol"},{"key":"2662_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","volume":"19","author":"LA Byers","year":"2013","unstructured":"Byers, L.A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P.K., et al. (2013). An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin Cancer Res 19, 279\u2013290.","journal-title":"Clin Cancer Res"},{"key":"2662_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.cell.2020.06.012","volume":"182","author":"YJ Chen","year":"2020","unstructured":"Chen, Y.J., Roumeliotis, T.I., Chang, Y.H., Chen, C.T., Han, C.L., Lin, M.H., Chen, H. W., Chang, G.C., Chang, Y.L., Wu, C.T., et al. (2020). Proteogenomics of non-smoking lung cancer in East Asia delineates molecular signatures of pathogenesis and progression. Cell 182, 226\u2013244.e17.","journal-title":"Cell"},{"key":"2662_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature13385","volume":"511","author":"EA Collisson","year":"2014","unstructured":"Collisson, E.A., Campbell, J.D., Brooks, A.N., Berger, A.H., Lee, W., Chmielecki, J., Beer, D.G., Cope, L., Creighton, C.J., Danilova, L., et al. (2014). Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543\u2013550.","journal-title":"Nature"},{"key":"2662_CR6","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11427-023-2491-7","volume":"67","author":"X Deng","year":"2024","unstructured":"Deng, X., Liao, T., Xie, J., Kang, D., He, Y., Sun, Y., Wang, Z., Jiang, Y., Miao, X., Yan, Y., et al. (2024). The burgeoning importance of PIWI-interacting RNAs in cancer progression. Sci China Life Sci 67, 653\u2013662.","journal-title":"Sci China Life Sci"},{"key":"2662_CR7","doi-asserted-by":"publisher","first-page":"898724","DOI":"10.3389\/fimmu.2022.898724","volume":"13","author":"Y Deng","year":"2022","unstructured":"Deng, Y., Wang, Y., Li, L., Miao, E.A., and Liu, P. (2022). Post-translational modifications of proteins in cytosolic nucleic acid sensing signaling pathways. Front Immunol 13, 898724.","journal-title":"Front Immunol"},{"key":"2662_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1097-2765(00)80133-1","volume":"2","author":"JMP Desterro","year":"1998","unstructured":"Desterro, J.M.P., Rodriguez, M.S., and Hay, R.T. (1998). SUMO-1 modification of I\u03baB\u03b1 inhibits NF-\u03baB activation. Mol Cell 2, 233\u2013239.","journal-title":"Mol Cell"},{"key":"2662_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3390\/biomedicines9091278","volume":"9","author":"L Espinosa","year":"2021","unstructured":"Espinosa, L., and Marruecos, L. (2021). NF-\u03baB-dependent and -independent (moonlighting) I\u03baB\u03b1 functions in differentiation and cancer. Biomedicines 9, 1278.","journal-title":"Biomedicines"},{"key":"2662_CR10","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s11427-023-2417-3","volume":"67","author":"C Fan","year":"2024","unstructured":"Fan, C., Xiong, F., Zhang, S., Gong, Z., Liao, Q., Li, G., Guo, C., Xiong, W., Huang, H., and Zeng, Z. (2024). Role of adhesion molecules in cancer and targeted therapy. Sci China Life Sci 67, 940\u2013957.","journal-title":"Sci China Life Sci"},{"key":"2662_CR11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.cell.2020.06.013","volume":"182","author":"MA Gillette","year":"2020","unstructured":"Gillette, M.A., Satpathy, S., Cao, S., Dhanasekaran, S.M., Vasaikar, S.V., Krug, K., Petralia, F., Li, Y., Liang, W.W., Reva, B., et al. (2020). Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma. Cell 182, 200\u2013225.e35.","journal-title":"Cell"},{"key":"2662_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40164-023-00420-3","volume":"12","author":"Y Gu","year":"2023","unstructured":"Gu, Y., Fang, Y., Wu, X., Xu, T., Hu, T., Xu, Y., Ma, P., Wang, Q., and Shu, Y. (2023). The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications. Exp Hematol Oncol 12, 58.","journal-title":"Exp Hematol Oncol"},{"key":"2662_CR13","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1038\/s41388-018-0641-1","volume":"38","author":"D Jang","year":"2019","unstructured":"Jang, D., Kwon, H., Choi, M., Lee, J., and Pak, Y. (2019). Sumoylation of Flotillin-1 promotes EMT in metastatic prostate cancer by suppressing Snail degradation. Oncogene 38, 3248\u20133260.","journal-title":"Oncogene"},{"key":"2662_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","volume":"567","author":"Y Jiang","year":"2019","unstructured":"Jiang, Y., Sun, A., Zhao, Y., Ying, W., Sun, H., Yang, X., Xing, B., Sun, W., Ren, L., Hu, B., et al. (2019). Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature 567, 257\u2013261.","journal-title":"Nature"},{"key":"2662_CR15","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.trecan.2020.11.009","volume":"7","author":"JS Kroonen","year":"2021","unstructured":"Kroonen, J.S., and Vertegaal, A.C.O. (2021). Targeting SUMO signaling to wrestle cancer. Trends Cancer 7, 496\u2013510.","journal-title":"Trends Cancer"},{"key":"2662_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40164-023-00394-2","volume":"12","author":"XM Li","year":"2023","unstructured":"Li, X.M., Zhao, Z.Y., Yu, X., Xia, Q.D., Zhou, P., Wang, S.G., Wu, H.L., and Hu, J. (2023a). Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy. Exp Hematol Oncol 12, 34.","journal-title":"Exp Hematol Oncol"},{"key":"2662_CR17","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.jtho.2023.08.011","volume":"18","author":"Y Li","year":"2023","unstructured":"Li, Y., Juergens, R.A., Finley, C., and Swaminath, A. (2023b). Current and future treatment options in the management of stage III NSCLC. J Thoracic Oncol 18, 1478\u20131491.","journal-title":"J Thoracic Oncol"},{"key":"2662_CR18","doi-asserted-by":"publisher","first-page":"eaba7791","DOI":"10.1126\/scitranslmed.aba7791","volume":"13","author":"ES Lightcap","year":"2021","unstructured":"Lightcap, E.S., Yu, P., Grossman, S., Song, K., Khattar, M., Xega, K., He, X., Gavin, J. M., Imaichi, H., Garnsey, J.J., et al. (2021). A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models. Sci Transl Med 13, eaba7791.","journal-title":"Sci Transl Med"},{"key":"2662_CR19","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.30917","volume":"71","author":"J Liu","year":"2020","unstructured":"Liu, J., Wu, Z., Han, D., Wei, C., Liang, Y., Jiang, T., Chen, L., Sha, M., Cao, Y., Huang, F., et al. (2020). Mesencephalic astrocyte-derived neurotrophic factor inhibits liver cancer through small ubiquitin-related modifier (SUMO)ylation-related suppression of NF-\u03baB\/snail signaling pathway and epithelial-mesenchymal transition. Hepatology 71, 1262\u20131278.","journal-title":"Hepatology"},{"key":"2662_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11427-023-2434-8","volume":"67","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Wang, Y., Liu, B., Liu, W., Ma, Y., Cao, Y., Yan, S., Zhang, P., Zhou, L., Zhan, Q., et al. (2024). Targeting lncRNA16 by GalNAc-siRNA conjugates facilitates chemotherapeutic sensibilization via the HBB\/NDUFAF5\/ROS pathway. Sci China Life Sci 67, 663\u2013679.","journal-title":"Sci China Life Sci"},{"key":"2662_CR21","doi-asserted-by":"publisher","first-page":"e52649","DOI":"10.15252\/embr.202152649","volume":"22","author":"L Marruecos","year":"2021","unstructured":"Marruecos, L., Bertran, J., \u00c1lvarez-Villanueva, D., Mulero, M.C., Guill\u00e9n, Y., Palma, L. G., Floor, M., Vert, A., Arce-Gallego, S., Pecharroman, I., et al. (2021). Dynamic chromatin association of I\u03baB\u03b1 is regulated by acetylation and cleavage of histone H4. EMBO Rep 22, e52649.","journal-title":"EMBO Rep"},{"key":"2662_CR22","doi-asserted-by":"publisher","first-page":"1213114","DOI":"10.3389\/fcell.2023.1213114","volume":"11","author":"R Molfetta","year":"2023","unstructured":"Molfetta, R., Petillo, S., Cippitelli, M., and Paolini, R. (2023). SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses. Front Cell Dev Biol 11, 1213114.","journal-title":"Front Cell Dev Biol"},{"key":"2662_CR23","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbrc.2022.05.065","volume":"615","author":"T Nishida","year":"2022","unstructured":"Nishida, T. (2022). SUMO-specific protease SENP3 enhances MDM2-mediated ubiquitination of PARIS\/ZNF746 in HeLa cells. Biochem Biophys Res Commun 615, 150\u2013156.","journal-title":"Biochem Biophys Res Commun"},{"key":"2662_CR24","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R.L., Miller, K.D., Wagle, N.S., and Jemal, A. (2023). Cancer statistics, 2023. CA Cancer J Clin 73, 17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"2662_CR25","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.4161\/cc.10.18.17436","volume":"10","author":"MH Stindt","year":"2011","unstructured":"Stindt, M.H., Carter, S.A., Vigneron, A.M., Ryan, K.M., and Vousden, K.H. (2011). MDM2 promotes SUMO-2\/3 modification of p53 to modulate transcriptional activity. Cell Cycle 10, 3176\u20133188.","journal-title":"Cell Cycle"},{"key":"2662_CR26","doi-asserted-by":"publisher","first-page":"103616","DOI":"10.1016\/j.drudis.2023.103616","volume":"28","author":"R Tasso","year":"2023","unstructured":"Tasso, R., Marconi, S., Rossi, G., Genova, C., and Coco, S. (2023). Platelets and their derived extracellular vesicles: the new generation of markers in non-small cell lung cancer management. Drug Discov Today 28, 103616.","journal-title":"Drug Discov Today"},{"key":"2662_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3892\/ijo.2021.5253","volume":"59","author":"L Wang","year":"2021","unstructured":"Wang, L., Qian, J., Yang, Y., and Gu, C. (2021a). Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review). Int J Oncol 59, 73.","journal-title":"Int J Oncol"},{"key":"2662_CR28","doi-asserted-by":"publisher","first-page":"729211","DOI":"10.3389\/fcell.2021.729211","volume":"9","author":"Q Wang","year":"2021","unstructured":"Wang, Q., Zhong, W., Deng, L., Lin, Q., Lin, Y., Liu, H., Xu, L., Lu, L., Chen, Y., Huang, J., et al. (2021b). The expression and prognostic value of SUMO1-activating enzyme subunit 1 and its potential mechanism in triple-negative breast cancer. Front Cell Dev Biol 9, 729211.","journal-title":"Front Cell Dev Biol"},{"key":"2662_CR29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wi\u015bniewski","year":"2009","unstructured":"Wi\u015bniewski, J.R., Zougman, A., Nagaraj, N., and Mann, M. (2009). Universal sample preparation method for proteome analysis. Nat Methods 6, 359\u2013362.","journal-title":"Nat Methods"},{"key":"2662_CR30","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu, F., Fan, J., He, Y., Xiong, A., Yu, J., Li, Y., Zhang, Y., Zhao, W., Zhou, F., Li, W., et al. (2021). Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat Commun 12, 2540.","journal-title":"Nat Commun"},{"key":"2662_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41392-023-01439-y","volume":"8","author":"X Wu","year":"2023","unstructured":"Wu, X., Xu, M., Geng, M., Chen, S., Little, P.J., Xu, S., and Weng, J. (2023). Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Sig Transduct Target Ther 8, 220.","journal-title":"Sig Transduct Target Ther"},{"key":"2662_CR32","doi-asserted-by":"publisher","first-page":"111450","DOI":"10.1016\/j.biopha.2021.111450","volume":"138","author":"S Xie","year":"2021","unstructured":"Xie, S., Wu, Z., Qi, Y., Wu, B., and Zhu, X. (2021). The metastasizing mechanisms of lung cancer: recent advances and therapeutic challenges. Biomed Pharmacother 138, 111450.","journal-title":"Biomed Pharmacother"},{"key":"2662_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.cell.2020.05.043","volume":"182","author":"JY Xu","year":"2020","unstructured":"Xu, J.Y., Zhang, C., Wang, X., Zhai, L., Ma, Y., Mao, Y., Qian, K., Sun, C., Liu, Z., Jiang, S., et al. (2020). Integrative proteomic characterization of human lung adenocarcinoma. Cell 182, 245\u2013261.","journal-title":"Cell"},{"key":"2662_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/19336918.2015.1016686","volume":"9","author":"W Xu","year":"2015","unstructured":"Xu, W., Yang, Z., and Lu, N. (2015). A new role for the PI3K\/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr 9, 317\u2013324.","journal-title":"Cell Adh Migr"},{"key":"2662_CR35","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/emboj\/cdg204","volume":"22","author":"H Yamamoto","year":"2003","unstructured":"Yamamoto, H. (2003). Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. EMBO J 22, 2047\u20132059.","journal-title":"EMBO J"},{"key":"2662_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12964-019-0392-9","volume":"17","author":"Y Yang","year":"2019","unstructured":"Yang, Y., Liang, Z., Xia, Z., Wang, X., Ma, Y., Sheng, Z., Gu, Q., Shen, G., Zhou, L., Zhu, H., et al. (2019). SAE1 promotes human glioma progression through activating AKT SUMOylation-mediated signaling pathways. Cell Commun Signal 17, 82.","journal-title":"Cell Commun Signal"},{"key":"2662_CR37","doi-asserted-by":"publisher","first-page":"27342","DOI":"10.1074\/jbc.M111.220848","volume":"286","author":"Q Yao","year":"2011","unstructured":"Yao, Q., Li, H., Liu, B.Q., Huang, X.Y., and Guo, L. (2011). SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses. J Biol Chem 286, 27342\u201327349.","journal-title":"J Biol Chem"},{"key":"2662_CR38","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11427-022-2216-x","volume":"66","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Zhao, D., Zhang, L., Xiao, Y., Wu, Q., Wang, Y., Chen, J., and Zhan, Q. (2023). Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma. Sci China Life Sci 66, 1245\u20131263.","journal-title":"Sci China Life Sci"},{"key":"2662_CR39","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1002\/mco2.261","volume":"4","author":"Q Zhong","year":"2023","unstructured":"Zhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023). Protein posttranslational modifications in health and diseases: functions, regulatory mechanisms, and therapeutic implications. MedComm 4, e261.","journal-title":"MedComm"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-023-2662-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-023-2662-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-023-2662-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T17:03:29Z","timestamp":1759597409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-023-2662-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2662"],"URL":"https:\/\/doi.org\/10.1007\/s11427-023-2662-y","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. All the animal experiments were approved by the Institutional Animal Care and Use Committee at the Cancer Hospital of the Chinese Academy of Medical Science. This study was approved by the Ethics Committee of the Cancer Hospital, Chinese Academy of Medical Sciences, with an exemption of informed consent, and was performed according to the principles outlined in the Declaration of Helsinki. This study was approved by the Research Ethics Committee of the National Cancer Center and Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}